Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and application of antibody framework region-targeted cross-linking mass spectrometry for epitope screening within patient-derived immune complexes. | J Pharm Biomed Anal | 2027 | 42759225 | PubTator, text mining | PubMed |
| H2S-scavenging bimetallic phenolic network induces metabolic reprogramming to sensitize colorectal cancer to cuproptosis and ferroptosis. | Biomaterials | 2027 | 42731546 | PubTator, text mining | PubMed |
| Roles of cuproptosis in central nervous system tumors: from molecular mechanisms to therapeutic prospects. | Front Cell Dev Biol | 2026 | 42812787 | PubTator, text mining | PubMed |
| AARS2-SIRT5-Driven DLD K445 Lactylation Promotes Cuproptosis Resistance in Glioblastoma Stem Cells. | Adv Sci (Weinh) | 2026 | 42806865 | PubTator, text mining | PubMed |
| Targeting FDX1 with oridonin triggers cuproptosis and inhibits tumor progression in nasopharyngeal carcinoma. | Int J Biochem Cell Biol | 2026 | 42800577 | PubTator, text mining | PubMed |
| Copper-regulated cell death after spinal cord injury: evidence boundaries for non-coding RNA, epigenetics and cuproptosis. | Front Mol Neurosci | 2026 | 42787557 | PubTator, text mining | PubMed |
| KDM4B Maintains Pyruvate Dehydrogenase Complex Expression to Support Mitochondrial Metabolism and Survival in Cancer Cells. | Epigenomes | 2026 | 42782835 | PubTator, text mining | PubMed |
| Cuproptosis: a novel mechanism linking placental metabolic stress to trophoblast injury in preeclampsia. | Front Endocrinol (Lausanne) | 2026 | 42780476 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps delivering lactylated S100a9 aggravate neuronal cuproptosis by regulating Ttr/Commd1/Atp7b axis after traumatic brain injury. | Redox Biol | 2026 | 42767162 | PubTator, text mining | PubMed |
Elesclomol-mediated cuproptosis overcomes cisplatin resistance by restricting epigenetically activated mitochondrial respiration: Novel therapeutic insights into cisplatin-elesclomol combination therapy. | Acta Pharm Sin B | 2026 | 42764935 | PubTator, text mining | PubMed |
| SOX2 Inhibits Cuproptosis to Affect Cisplatin Resistance in Non-Small Cell Lung Cancer by Activating the Wnt/ATP7B Signaling Pathway. | Kaohsiung J Med Sci | 2026 | 42757550 | PubTator, text mining | PubMed |
| Copper ion-induced MYH9 polymerization executes cuproptosis. | Cell | 2026 | 42735689 | PubTator, text mining | PubMed |
| UBE2D4 Upregulation Promotes Cuproptosis Sensitivity in Colorectal Cancer. | Mol Genet Genomic Med | 2026 | 42734261 | PubTator, text mining | PubMed |
| Cuproptosis and copper metabolism regulate hepatocellular carcinoma progression and therapeutic response to sorafenib. | Exp Cell Res | 2026 | 42716418 | PubTator, text mining | PubMed |
| Metabolic-cell-death gene trio predicts survival and cuproptosis sensitivity in colorectal cancer. | J Gastrointest Oncol | 2026 | 42703393 | PubTator, text mining | PubMed |
| A copper-based nanotherapeutic overcomes multidrug- resistant breast cancer by blocking drug efflux and triggering cuproptosis. | Colloids Surf B Biointerfaces | 2026 | 42696812 | PubTator, text mining | PubMed |
| Copper, cuproptosis, and cancer: biology concepts of a novel cell death. | Apoptosis | 2026 | 42693224 | PubTator, text mining | PubMed |
| Plasma proteomics reveals the molecular features in rapidly progressive pneumoconiosis. | Front Immunol | 2026 | 42666288 | PubTator, text mining | PubMed |
| Functional role of LAMC1 in modulating cuproptosis in glioma cells. | Biochim Biophys Acta Mol Cell Res | 2026 | 42665028 | PubTator, text mining | PubMed |
| DIXDC1 Promotes Lymphatic Metastasis and Resistance to Cuproptosis in Bladder Cancer Through Mediating DLAT. | Adv Sci (Weinh) | 2026 | 42658569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers